- Helps in controlling blood sugar levels in patients with type 2 diabetes mellitus.
- Reduces the risk of diabetes-related complications such as neuropathy and retinopathy.
- Improves insulin sensitivity and promotes better glucose uptake by cells.
- Decreases hepatic glucose production, contributing to overall glycemic control.
- Increases urinary glucose excretion, aiding in weight management.
- May provide cardiovascular benefits by improving heart health in diabetic patients.
- Can be used as part of a comprehensive diabetes management plan alongside diet and exercise.
GemerDapa 5/1/500 Tablet - Strip of 7
Compositions : Dapagliflozin 5mg + Glimepiride 1mg + Metformin 500mg
MRP :
MRP :
In stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Sun Pharmaceutical Industries Ltd
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
GemerDapa 5/1/500 Tablet is a pharmaceutical product designed to aid in the management of type 2 diabetes mellitus. This medication combines three active ingredients: Metformin, Dapagliflozin, and Glimepiride, each contributing to its therapeutic efficacy. Metformin is a biguanide that primarily works by decreasing hepatic glucose production and improving insulin sensitivity, thereby enhancing glucose uptake by peripheral tissues. Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, functions by preventing glucose reabsorption in the kidneys, leading to increased glucose excretion through urine. Glimepiride, a sulfonylurea, stimulates insulin secretion from pancreatic beta cells, further aiding in blood sugar control. Together, these components create a synergistic effect that helps lower blood sugar levels effectively. GemerDapa 5/1/500 Tablet is prescribed for patients who require multiple mechanisms of action to achieve optimal glycemic control. It is particularly beneficial for individuals who have not achieved adequate control with monotherapy or those who are at risk of complications associated with uncontrolled diabetes. The combination of these three agents not only addresses hyperglycemia but also offers potential cardiovascular benefits, making it a comprehensive option for managing diabetes. Patients using GemerDapa 5/1/500 Tablet should be aware of the importance of adhering to prescribed dosages and maintaining regular follow-ups with their healthcare provider to monitor their condition and adjust treatment as necessary.
Product Details
- Metformin decreases glucose production in the liver and enhances insulin sensitivity.
- Dapagliflozin inhibits SGLT2, leading to increased glucose excretion through urine.
- Glimepiride stimulates insulin secretion from the pancreas, lowering blood sugar levels.
- The combination of these actions results in improved glycemic control.
- Helps reduce the risk of long-term complications associated with diabetes.
- Take GemerDapa 5/1/500 Tablet orally with a glass of water.
- Dosage is typically prescribed by a healthcare provider based on individual needs.
- Commonly recommended dosage is one tablet taken once daily.
- It is advisable to take the tablet at the same time each day for consistency.
- Do not crush or chew the tablet; swallow it whole.
- Follow your healthcare provider's instructions regarding timing and frequency of use.
- Continue taking the medication even if you feel well; do not stop without consulting your doctor.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables to support blood sugar control.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise weekly.
- Monitor blood sugar levels regularly to understand how your body responds to the medication.
- Stay hydrated and limit sugary beverages to help manage weight and blood sugar levels.
- Avoid smoking and limit alcohol consumption as they can affect blood sugar control.
Safety Advice
Side Effects
- Common side effects may include nausea, vomiting, diarrhea, and abdominal discomfort.
- Dizziness or headache may occur as your body adjusts to the medication.
- Serious side effects can include low blood sugar (hypoglycemia), which may present as sweating, shakiness, confusion, or fainting.
- Seek immediate medical attention if you experience symptoms of lactic acidosis such as unusual muscle pain, difficulty breathing, or feeling cold and dizzy.
- If you notice any signs of allergic reactions like rash, itching, or swelling, contact your healthcare provider promptly.
Precautions and Warnings
- Do not use GemerDapa 5/1/500 Tablet if you have a known allergy to any of its components.
- Patients with severe kidney or liver impairment should avoid this medication.
- Alcohol consumption should be limited as it can increase the risk of hypoglycemia.
- Consult your doctor if you are pregnant or breastfeeding before using this medication.
- Be cautious when driving or operating machinery until you know how GemerDapa 5/1/500 Tablet affects you.
- Regular monitoring of kidney function is recommended during treatment.
FAQs
GemerDapa 5/1/500 Tablet may not be suitable for individuals with certain medical conditions. Always consult your healthcare provider before starting this medication.
2. What should I do if I miss a dose?
If you miss a dose of GemerDapa 5/1/500 Tablet, take it as soon as you remember. If it's almost time for your next dose, skip the missed dose and continue with your regular schedule.
3. Can I take GemerDapa 5/1/500 Tablet with other medications?
Inform your doctor about all medications you are taking, as GemerDapa 5/1/500 Tablet may interact with certain drugs.
4. How should I store GemerDapa 5/1/500 Tablet?
Store GemerDapa 5/1/500 Tablet at room temperature away from moisture and heat. Keep it out of reach of children.
5. What are the common side effects?
Common side effects may include nausea, headache, and dizziness. Contact your doctor if you experience severe side effects.
6. Can pregnant or breastfeeding women use GemerDapa 5/1/500 Tablet?
Pregnant or breastfeeding women should consult their healthcare provider before using GemerDapa 5/1/500 Tablet.
7. How long will I need to take this medication?
The duration of treatment with GemerDapa 5/1/500 Tablet will depend on your individual health needs and should be determined by your healthcare provider.
Instructions
No content available for this section.
More Information
| SKU | 296124 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Sun Pharmaceutical Industries Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Seller | Kogland Commerce Pvt Ltd (TN) |
GemerDapa 5/1/500 Tablet is a pharmaceutical product designed to aid in the management of type 2 diabetes mellitus. This medication combines three active ingredients: Metformin, Dapagliflozin, and Glimepiride, each contributing to its therapeutic efficacy. Metformin is a biguanide that primarily works by decreasing hepatic glucose production and improving insulin sensitivity, thereby enhancing glucose uptake by peripheral tissues. Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, functions by preventing glucose reabsorption in the kidneys, leading to increased glucose excretion through urine. Glimepiride, a sulfonylurea, stimulates insulin secretion from pancreatic beta cells, further aiding in blood sugar control. Together, these components create a synergistic effect that helps lower blood sugar levels effectively. GemerDapa 5/1/500 Tablet is prescribed for patients who require multiple mechanisms of action to achieve optimal glycemic control. It is particularly beneficial for individuals who have not achieved adequate control with monotherapy or those who are at risk of complications associated with uncontrolled diabetes. The combination of these three agents not only addresses hyperglycemia but also offers potential cardiovascular benefits, making it a comprehensive option for managing diabetes. Patients using GemerDapa 5/1/500 Tablet should be aware of the importance of adhering to prescribed dosages and maintaining regular follow-ups with their healthcare provider to monitor their condition and adjust treatment as necessary.
- Helps in controlling blood sugar levels in patients with type 2 diabetes mellitus.
- Reduces the risk of diabetes-related complications such as neuropathy and retinopathy.
- Improves insulin sensitivity and promotes better glucose uptake by cells.
- Decreases hepatic glucose production, contributing to overall glycemic control.
- Increases urinary glucose excretion, aiding in weight management.
- May provide cardiovascular benefits by improving heart health in diabetic patients.
- Can be used as part of a comprehensive diabetes management plan alongside diet and exercise.
- Metformin decreases glucose production in the liver and enhances insulin sensitivity.
- Dapagliflozin inhibits SGLT2, leading to increased glucose excretion through urine.
- Glimepiride stimulates insulin secretion from the pancreas, lowering blood sugar levels.
- The combination of these actions results in improved glycemic control.
- Helps reduce the risk of long-term complications associated with diabetes.
- Take GemerDapa 5/1/500 Tablet orally with a glass of water.
- Dosage is typically prescribed by a healthcare provider based on individual needs.
- Commonly recommended dosage is one tablet taken once daily.
- It is advisable to take the tablet at the same time each day for consistency.
- Do not crush or chew the tablet; swallow it whole.
- Follow your healthcare provider's instructions regarding timing and frequency of use.
- Continue taking the medication even if you feel well; do not stop without consulting your doctor.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables to support blood sugar control.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise weekly.
- Monitor blood sugar levels regularly to understand how your body responds to the medication.
- Stay hydrated and limit sugary beverages to help manage weight and blood sugar levels.
- Avoid smoking and limit alcohol consumption as they can affect blood sugar control.
Side Effects
- Common side effects may include nausea, vomiting, diarrhea, and abdominal discomfort.
- Dizziness or headache may occur as your body adjusts to the medication.
- Serious side effects can include low blood sugar (hypoglycemia), which may present as sweating, shakiness, confusion, or fainting.
- Seek immediate medical attention if you experience symptoms of lactic acidosis such as unusual muscle pain, difficulty breathing, or feeling cold and dizzy.
- If you notice any signs of allergic reactions like rash, itching, or swelling, contact your healthcare provider promptly.
Precautions and Warnings
- Do not use GemerDapa 5/1/500 Tablet if you have a known allergy to any of its components.
- Patients with severe kidney or liver impairment should avoid this medication.
- Alcohol consumption should be limited as it can increase the risk of hypoglycemia.
- Consult your doctor if you are pregnant or breastfeeding before using this medication.
- Be cautious when driving or operating machinery until you know how GemerDapa 5/1/500 Tablet affects you.
- Regular monitoring of kidney function is recommended during treatment.
GemerDapa 5/1/500 Tablet may not be suitable for individuals with certain medical conditions. Always consult your healthcare provider before starting this medication.
2. What should I do if I miss a dose?
If you miss a dose of GemerDapa 5/1/500 Tablet, take it as soon as you remember. If it's almost time for your next dose, skip the missed dose and continue with your regular schedule.
3. Can I take GemerDapa 5/1/500 Tablet with other medications?
Inform your doctor about all medications you are taking, as GemerDapa 5/1/500 Tablet may interact with certain drugs.
4. How should I store GemerDapa 5/1/500 Tablet?
Store GemerDapa 5/1/500 Tablet at room temperature away from moisture and heat. Keep it out of reach of children.
5. What are the common side effects?
Common side effects may include nausea, headache, and dizziness. Contact your doctor if you experience severe side effects.
6. Can pregnant or breastfeeding women use GemerDapa 5/1/500 Tablet?
Pregnant or breastfeeding women should consult their healthcare provider before using GemerDapa 5/1/500 Tablet.
7. How long will I need to take this medication?
The duration of treatment with GemerDapa 5/1/500 Tablet will depend on your individual health needs and should be determined by your healthcare provider.
No content available for this section.
| SKU | 296124 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Sun Pharmaceutical Industries Ltd |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account